Atlas Trials

Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study

Clinical trial NCT05997901 · COMPLETED

Trial details

NCT number
NCT05997901
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Medication AdherenceSmoking Cessation
Start date
2024-06-01
Primary completion
2025-04-23
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.